Sphingosine kinases
    1.
    发明授权
    Sphingosine kinases 失效
    鞘氨醇激酶

    公开(公告)号:US06858427B2

    公开(公告)日:2005-02-22

    申请号:US09784810

    申请日:2001-02-14

    摘要: Disclosed herein are novel human nucleic acid sequences that encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

    摘要翻译: 本文公开了编码多肽的新型人核酸序列。 还公开了由这些核酸序列编码的多肽,以及免疫特异性结合多肽的抗体,以及上述多肽,多核苷酸或抗体的衍生物,变体,突变体或片段。 本发明还公开了用于诊断,治疗和预防与这些新型人核酸和蛋白质中的任一种相关的病症的治疗,诊断和研究方法。